Location: New York, NY
CIK: 0001609251 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 15, 2024
Total Value: $178M
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 100,332 | $35.95M | 20.1% | $127.97 | +164.0% | — | 91307C102 |
| EXEL | EXELIXIS INC | 1,281,612 | $33.26M | 18.6% | $18.73 | +32.7% | — | 30161Q104 |
| CAH | CARDINAL HEALTH INC | 210,263 | $23.24M | 13.0% | $56.53 | +81.0% | — | 14149Y108 |
| BIIB | BIOGEN INC | 113,502 | $22M | 12.3% | $267.94 | -21.9% | — | 09062X103 |
| ENTA | ENANTA PHARMACEUTICALS INC | 1,498,074 | $15.52M | 8.7% | $27.36 | -52.2% | — | 29251M106 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 110,257 | $12.28M | 6.9% | $123.54 | -11.3% | — | G50871105 |
| BNTX | BIONTECH SE-ADR | 93,583 | $11.12M | 6.2% | $91.15 | — | — | 09075V102 |
| SNY | SANOFI-ADR | 150,205 | $8.656M | 4.9% | $49.70 | — | — | 80105N105 |
| ALKS | ALKERMES PLC | 251,495 | $7.039M | 3.9% | $18.83 | +41.6% | — | G01767105 |
| — | INDIVIOR PLC | 701,873 | $6.843M | 3.8% | $9.75 | — | — | G4766E116 |
| VNDA | VANDA PHARMACEUTICALS INC | 414,684 | $1.945M | 1.1% | $5.16 | +3.8% | — | 921659108 |
| REGN | REGENERON PHARMACEUTICALS | 353 | $371K | 0.2% | $342.96 | +222.7% | — | 75886F107 |
| — | MURAL ONCOLOGY PLC | 75,868 | $237K | 0.1% | $5.89 | — | — | G63365103 |